2016
DOI: 10.1016/j.pan.2016.05.004
|View full text |Cite
|
Sign up to set email alerts
|

Impact of 3′UTR variation patterns of the KRAS gene on the aggressiveness of pancreatobiliary tumors with the KRAS G13D mutation in a Turkish population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 36 publications
1
1
0
Order By: Relevance
“…Kras codon 13 mutations were reported to have a frequency of ∼7% in pancreatic ductal adenocarcinoma cases ( Buscail et al., 2020b ), including the one (GGC→GAC) shown in this study. Besides our present work, Kras codon 13 mutations were also observed in some other tumor types, such as gastric cancer, lung cancer, colorectal cancer, ovarian cancer, prostate cancer, and pancreatobiliary tumor ( Ayatollahi et al., 2018 ; Egeli et al., 2016 ; Silan et al., 2012 ). A meta-analysis of eight research papers suggests that codon 13 mutations of Kras gene seem to correlate with a worse overall survival of patients with colorectal cancer, but the overall survival is similar to those with Kras wild type in patients receiving anti-EGFR therapy ( Kwak et al., 2017 ).…”
Section: Discussionsupporting
confidence: 74%
“…Kras codon 13 mutations were reported to have a frequency of ∼7% in pancreatic ductal adenocarcinoma cases ( Buscail et al., 2020b ), including the one (GGC→GAC) shown in this study. Besides our present work, Kras codon 13 mutations were also observed in some other tumor types, such as gastric cancer, lung cancer, colorectal cancer, ovarian cancer, prostate cancer, and pancreatobiliary tumor ( Ayatollahi et al., 2018 ; Egeli et al., 2016 ; Silan et al., 2012 ). A meta-analysis of eight research papers suggests that codon 13 mutations of Kras gene seem to correlate with a worse overall survival of patients with colorectal cancer, but the overall survival is similar to those with Kras wild type in patients receiving anti-EGFR therapy ( Kwak et al., 2017 ).…”
Section: Discussionsupporting
confidence: 74%
“…Pathogenic variant (C>T, 112445441, Gly13Asprs) was repeated in 2 patients; IDs 5 and 16. This mutation (Gly13Asprs) was associated with invasive pancreatobiliary tumors in Turkish population [24]. Pathogenic variant (rs121913529) was also identified in 2 patients; IDs 4 and 11.…”
Section: Kras Pathogenic and Likely Pathogenic Variantsmentioning
confidence: 87%